Peripheral Intervention was Merit Medical Systems’s largest segment in fiscal 2025, bringing in $341.94M of $1.02B (34%).
| Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Cardiovascular | — | — | |||||||||||||
| Peripheral Intervention | $263.60M | $341.94M | |||||||||||||
| Cardiac Intervention | $214.48M | $187.36M | |||||||||||||
| Custom Procedural Solutions | $108.78M | $209.33M | |||||||||||||
| Stand-Alone Devices | — | — | |||||||||||||
| Stand Alone Devices | — | — | |||||||||||||
| Oem | $145.03M | $204.96M | |||||||||||||
| Custom Kits & Procedure Trays | — | — | |||||||||||||
| Custom Kit & Procedures Trays | — | — | |||||||||||||
| Catheters | — | — | |||||||||||||
| Inflation Devices | — | — | |||||||||||||
| Embolization Devices | — | — | |||||||||||||
| Crm/Ep | — | — | |||||||||||||
| Electrophysiology | — | — | |||||||||||||
| Endoscopy Devices | $32.76M | $72.86M | |||||||||||||
| Total | $764.65M | $1.02B |
Merit Medical Systems brought in $1.02B from its five segments in fiscal 2025, the year ended December 31, 2025. That was up 32.9% from $764.65M in fiscal 2022, the previous year with figures. Peripheral Intervention was the largest at $341.94M (33.6%), ahead of Custom Procedural Solutions at $209.33M (20.6%) and Oem at $204.96M (20.2%). The other two segments brought in $260.22M combined.
Compared with fiscal 2022, the previous year with figures, Endoscopy Devices grew fastest, up 122.4% to $72.86M, while Cardiac Intervention fell the most, down 12.6% to $187.36M. From fiscal 2022 to 2025, combined revenue from these segments grew from $764.65M to $1.02B, a compound annual growth rate of 10.0%. Peripheral Intervention's share of the total fell from 34.5% to 33.6%.
United States was Merit Medical Systems’s largest region in fiscal 2025, bringing in $341.94M of $603.50M (57%).
| Geography | FY 2009 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| United States | $280.82M | $312.67M | $341.94M | |
| International | $212.94M | $220.99M | $261.56M | |
| Foreign Sales | — | — | — | |
| Total | $493.75M | $533.66M | $603.50M |
Merit Medical Systems brought in $603.50M from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $1.02B it reports by segment, so these regions do not cover all of its revenue. United States was the largest at $341.94M (56.7%), ahead of International at $261.56M (43.3%).
Compared with fiscal 2024, International grew 18.4% to $261.56M and United States grew 9.4% to $341.94M.
Merit Medical Systems (MMSI) reports its revenue by segment and by geography. In fiscal 2025, Peripheral Intervention was its largest segment, bringing in $341.94M (33.6% of the total), followed by Custom Procedural Solutions at $209.33M (20.6%).
Peripheral Intervention was Merit Medical Systems' largest segment in fiscal 2025, bringing in $341.94M, or 33.6% of the $1.02B total across its five segments.
United States was Merit Medical Systems' largest region in fiscal 2025, bringing in $341.94M, or 56.7% of the $603.50M total across its two regions.
International grew faster than United States in fiscal 2025, up 18.4% from $220.99M to $261.56M. United States grew 9.4% to $341.94M.
Every figure comes from Merit Medical Systems' annual financial filings, as reported. Each line keeps the name Merit Medical Systems gives it, and years follow its fiscal calendar.
Merit Medical Systems' revenue by segment goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.